Moreover, in the series of in vitro experiments with primary MG treated with pro-inflammatory cytokines, a positive correlation was found between Ifi27l2a and IRF7, implying that IRF7 signaling may contribute to Ifi27l2a expression in activated MG. The gene discussed is IRF7; the disease is myasthenia gravis.